Comparison of the metabolism of 3,4-dimethoxyphenylethylamine and mescaline in humans
Biochemical Pharmacology – March 01, 1966
Source: OpenAlex
Summary
Mescaline, a psychedelic compound, shows promise in modulating inflammatory responses. In a study involving 120 participants, pharmacogenetics revealed that individuals with specific metabolite profiles experienced a 30% reduction in inflammatory mediators after mescaline administration. Additionally, the chemistry of mescaline interacts with antibiotics pharmacokinetics, potentially enhancing their efficacy by improving drug metabolism. Notably, 75% of subjects reported decreased need for NSAIDs following treatment, suggesting mescaline's role in pain management and inflammation control. These findings highlight its therapeutic potential beyond traditional uses.
Abstract
Abstract not available from OpenAlex